![Martin Simonetti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Simonetti
Chief Executive Officer at
PBS Biotech, Inc.
Profile
Martin A. Simonetti is Chief Executive Officer at PBS Biotech, Inc. since 2025.
Mr. Simonetti is Director at Curtana Pharmaceuticals, Inc. since 2015.
Mr. Simonetti is Director at LoveMyDelta, Inc. Mr. Simonetti is Director at Eisana Corp.
Formerly, Mr. Simonetti was President & Chief Executive Officer at Viral Logic Systems Technology Corp.
from 2005 to 2011.
Mr. Simonetti was Chairman at Nexgenia, Inc. Mr. Simonetti was Independent Director at Alexandria Real Estate Equities, Inc. from 2011 to 2013.
Mr. Simonetti was Independent Director at Neusentis, Inc. in 2011.
Mr. Simonetti was Director at Prismic Pharmaceuticals, Inc. Mr. Simonetti was Director at EpiThany, Inc. Mr. Simonetti was Vice President-Operations & Finance at Amgen, Inc. in 1998.
Mr. Simonetti was Group Controller at Genentech, Inc. in 1991.
Mr. Simonetti was Chief Financial Officer, Treasurer & SVP-Finance at Dendreon Corp.
from 1999 to 2005.
Education includes an MBA from Santa Clara University and graduate studies at the University of California, Davis.
Martin Simonetti active positions
| Companies | Position | Start |
|---|---|---|
Curtana Pharmaceuticals, Inc.
 Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing of therapies for the treatment of brain cancer | Director/Board Member | 01/08/2015 |
LoveMyDelta, Inc.
 LoveMyDelta, Inc. Information Technology ServicesTechnology Services Provides technology services | Director/Board Member | - |
PBS Biotech, Inc.
 PBS Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Manufactures bioreactors | Chief Executive Officer | 27/10/2025 |
Eisana Corp.
 Eisana Corp. Medical SpecialtiesHealth Technology Manufactures tech-enabled products aimed at mitigating the side effects of cancer treatment | Director/Board Member | - |
Former positions of Martin Simonetti
| Companies | Position | End |
|---|---|---|
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | Director/Board Member | 20/05/2013 |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Director/Board Member | 27/10/2011 |
| DENDREON CORPORATION | Director of Finance/CFO | 10/06/2005 |
| AMGEN INC. | Director of Finance/CFO | 01/01/1998 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Comptroller/Controller/Auditor | 01/01/1991 |
Training of Martin Simonetti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Alexandria Real Estate Equities, Inc.
 Alexandria Real Estate Equities, Inc. Real Estate Investment TrustsFinance Operates as a real estate investment trust which leases life science, agri-tech, and advanced technology mega campuses | Finance |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel orally administered small molecule drugs | Health Technology |
Nexgenia, Inc.
 Nexgenia, Inc. Medical SpecialtiesHealth Technology Develops stimuli-responsive polymers and polymer-containing magnetic nanoparticles | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for autoimmune and inflammatory disorders | Health Technology |
PBS Biotech, Inc.
PBS Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Manufactures bioreactors | Commercial Services |
Prismic Pharmaceuticals, Inc.
 Prismic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
EpiThany, Inc.
 EpiThany, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company that develops therapeutic vaccines for a variety of solid tumours | Commercial Services |
Curtana Pharmaceuticals, Inc.
Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing of therapies for the treatment of brain cancer | Health Technology |
LoveMyDelta, Inc.
LoveMyDelta, Inc. Information Technology ServicesTechnology Services Provides technology services | Technology Services |
Eisana Corp.
Eisana Corp. Medical SpecialtiesHealth Technology Manufactures tech-enabled products aimed at mitigating the side effects of cancer treatment | Health Technology |
- Stock Market
- Insiders
- Martin Simonetti
